OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
December 27, 2022
How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information
November 10, 2022
While this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue
October 17, 2022
Wholesalers continue to worry about manufacturer commitment to timely compliance
September 26, 2022
Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape
September 12, 2022
Allows CDMO’s regulatory, consulting services to further expand into the pharma market
September 09, 2022
Law firm to feature life sciences practice in New Jersey and Philadelphia
September 06, 2022
Innovation in pharma manufacturing as paradigms shift and biotech and personalized therapies move through clinical trials at pace
September 01, 2022
Location expands company’s pharmacovigilance, regulatory affairs services
August 18, 2022
Partnership adds technological offerings to PharmaLex’s repertoire
August 16, 2022
As a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.